A panel of vaccine advisers at the Food and Drug Administration will meet Friday to discuss whether the agency should grant emergency use authorization to the COVID-19 vaccine developed by Johnson & Johnson-owned Janssen Pharmaceuticals. Here are the answers to the most pressing questions.
How efficacious is the vaccine?
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.